Keywords:
Rh alloimmunization; plasmapheresis; intravenous immunoglobulin; intrauterine transfusion; fetal anemiaReferences
1. Hanson MD, Groh D, Barsoom M. Use of therapeutic plasma exchange and intravenous immunoglobulin to prevent complications in a K+ sensitized pregnancy. Cureus. 2024;16(10): e72254. doi:10.7759/cureus.72254.
2. Kilby MD, Bussel JB, Moise KJ Jr. The contemporary management of haemolytic disease of the fetus and newborn. Vox Sang. 2025;120(7):644-652. doi:10.1111/vox.70027.
3. Maisonneuve E, Toly-Ndour C, Jouannic JM. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn. Am J Obstet Gynecol. 2019;220(3):288. doi:10.1016/j.ajog.2018.10.025.
4. Malik H, Verweij EJT, Mustafa HJ. Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2025;102: 102646. doi:10.1016/j.bpobgyn.2025.102646.
5. Mari G, Norton ME, Stone J, et al; Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia—diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697-710. doi:10.1016/j.ajog.2015.01.059.
6. Mustafa HJ, Sambatur EV, Pagani G, et al. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis. Am J Obstet Gynecol. 2024;231(4):417-429.e21. doi:10.1016/j.ajog.2024.03.044.
7. Nwogu LC, Moise KJ Jr, Klein KL, et al. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion. Transfusion. 2018;58(3):677-684. doi:10.1111 /trf.14453.
8. Regan F, Veale K, Robinson F, et al. Guideline for the investigation and management of red cell antibodies in pregnancy: A British Society for Haematology guideline. Transfus Med. 2025;35(1):3-23. doi:10.1111/tme.13098.
9. Ruma MS, Moise KJ Jr, Kim E, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol. 2007;196(2):138.e1-138.e6. doi:10.1016/j.ajog.2006.10.890.
10. Winter DP, Verweij EJT, Debeer A, et al; Worldwide Collaboration for Hemolytic Disease of the Fetus and Newborn (DIONYSUS) Investigators. Variations and opportunities in postnatal management of hemolytic disease of the fetus and newborn. JAMA Netw Open. 2025;8(1):e2454330. doi:10.1001/jamanetworkopen.2024.54330.
11. Zwiers C, van der Bom JG, van Kamp IL, et al. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn. Am J Obstet Gynecol. 2018;219(3):291.e1-291.e9. doi:10.1016/j.ajog.2018. 06.007.
